DCELL BIO-LOGIC INNOVATION
DEAD

Serial Number

86081474

Owner

Tissue Regenix Group Plc

Attorney

Scott D. Woldow

Filing Date

Oct 3, 2013

Add to watchlist:

No watchlists yet
View on USPTO

DCELL BIO-LOGIC INNOVATION Trademark

Serial Number: 86081474

DCELL BIO-LOGIC INNOVATION is a trademark filed by Tissue Regenix Group Plc on October 3, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Tissue Regenix Group Plc (7 trademarks)

The Biocentre, Innovation Way
Heslington, York YO105NY , GB

Entity Type: 99

Trademark Details

Filing Date

October 3, 2013

Registration Date

Not Registered

Goods & Services

treatment of living cells and tissue, namely, removing immunologic materials

Replacement materials for animal and human tissue, namely, biological tissues, namely, skin, skin grafts, ureter tissue, bladders, tendons, cartilage, ligaments, blood vessels, nerves, soft tissue for use in the heart and pericardium intended for subsequent implantation; surgical implants comprising living tissue; surgical implants comprising living tissue, namely, vascular patches, meniscus, aortic heart valves, blood vessels, ligaments, cartilage, bone; tissue regeneration materials, namely, human allograft or autograft tissue; Biological implants, namely, a vital processed human or animal connective tissue, namely, xenograft tissue; biological implants for guided tissue regeneration, namely, a vital processed human or animal connective tissue; arterial grafts; human allograft tissue formed for use as a surgical patch; Biological implants, namely, a vital processed human or animal connective tissue, namely, heart valve implants comprising human or animal tissues; small diameter skin grafts

Surgical implants comprising artificial tissue, namely, non-living surgical implants originally derived from humans and animals intended for subsequent implantation comprising bone, skin, skin grafts, ureters, bladders, tendons, cartilage, ligaments, blood vessels, nerves, soft tissue for use in the heart and pericardium; surgical implants comprising textile material to encourage the growth of tissue, namely, medical, surgical and orthopaedics implants made of artificial textile materials; surgical implants and mesh made of synthetic materials for use in soft tissue; surgical and intravascular implants comprised of artificial textile material

Medical research and scientific research in the field of replacement tissues for humans and animals, regenerative medical devices

Filing History

ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Jul 23, 2018 MAB1
ABANDONMENT - EXPRESS MAILED
Jul 23, 2018 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jul 20, 2018 EXAR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 6, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 6, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 6, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 21, 2018 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 20, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 19, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 19, 2017 GNSL
SUSPENSION LETTER WRITTEN
Jun 19, 2017 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 13, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 12, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 12, 2016 GNSL
SUSPENSION LETTER WRITTEN
Dec 12, 2016 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 12, 2016 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 9, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 9, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jun 9, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 7, 2016 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 7, 2015 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 7, 2015 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 7, 2015 CNSI
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2015 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 4, 2015 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 8, 2015 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 8, 2015 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 8, 2015 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 8, 2015 RCCK
ASSIGNED TO LIE
Jun 2, 2015 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 24, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 24, 2014 GNSL
SUSPENSION LETTER WRITTEN
Nov 24, 2014 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 21, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
May 21, 2014 GNSL
SUSPENSION LETTER WRITTEN
May 21, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2014 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2013 NWOS
NEW APPLICATION ENTERED
Oct 7, 2013 NWAP